港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

銀諾醫藥-B

3.275

+0.0752.34%

成交量：216.06萬

成交額：696.99萬

市值：14.97億

市盈率：-4.15

高：3.295

開：3.220

低：3.130

收：3.200

52周最高：48.360

52周最低：3.130

股本：4.57億

香港流通股本：4.20億

量比：0.39

換手率：0.51%

股息：- -

股息率：- -

每股收益(LYR):-0.790

淨資產收益率：-41.16%

總資產收益率：-19.04%

市淨率：1.35

市盈率(LYR):-4.15

市銷率: 8.30

資料載入中...

總覽公司新聞資訊公告

銀諾醫藥-B(02591.HK)：金柏獲委任為公司副總裁

銀諾醫藥-B（02591）任命金柏為副總裁負責全球商業化佈局

銀諾醫藥-B：委任金柏為副總裁

南方财经网

銀諾醫藥-B任命Jin Bai為副總裁自2026年10月19日起生效

年內股價暴跌88%後，銀諾醫藥再迎人事震盪：商業化「操盤手」徐文潔辭任

銀諾醫藥商業化一號位徐文潔辭任，核心產品依蘇帕格魯肽α醫保落地正處爬坡期

红星资本局

銀諾醫藥-B宣佈兩名董事辭任並調整戰略委員會成員

銀諾醫藥-B(02591.HK)：徐文潔辭任執行董事

銀諾醫藥－Ｂ(02591)股價上升5.075%，現價港幣$3.83

阿斯达克财经

銀諾醫藥-B：9月股本保持穩定，未有新增發行或回購

銀諾醫藥-B2026年中期營收7,821.80萬元按年增長38.56%

銀諾醫藥－Ｂ(02591)股價下跌5.045%，現價港幣$3.67

阿斯达克财经

黃冰增持銀諾醫藥-B(02591.HK)2400股每股作價3.89港元

銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至2.48%

銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至2.48%

銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例由3.43%降至2.48%

銀諾醫藥-B：Cowin Capital Investment II LTD減持，好倉比例降至2.48%

銀諾醫藥-B：黃荔減持，好倉比例降至4.66%

銀諾醫藥-B：鄭偉鶴減持，好倉比例降至4.66%

銀諾醫藥-B：鄭偉鶴減持，好倉比例降至5.9%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/02591/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"銀諾醫藥-B","latestPrice":3.275,"timestamp":1792742889003,"preClose":3.2,"halted":0,"volume":2160600,"delay":0,"changeRate":0.023437499999999917,"floatShares":420285370,"shares":457000000,"eps":-0.79,"marketStatus":"休市中","change":0.075,"latestTime":"10-23 16:08:09","open":3.22,"high":3.295,"low":3.13,"amount":6969871,"amplitude":0.051563,"askPrice":3.275,"askSize":3000,"bidPrice":3.26,"bidSize":6800,"shortable":3,"etf":0,"ttmEps":-0.853301,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":7,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":3.2,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":0.391407370896323,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-19.04%","roe":"-41.16%","lyrEps":-0.79,"volumeRatio":0.391407370896323,"shares":457000000,"dividePrice":0,"high":3.295,"amplitude":0.051563,"preClose":3.2,"low":3.13,"week52Low":3.13,"pbRate":"1.35","psRate":"8.30","week52High":48.36,"institutionHeld":0,"latestPrice":3.275,"committee":0.387755,"eps":-0.79,"divideRate":0,"volume":2160600,"delay":0,"ttmEps":-0.853301,"open":3.22,"prevYearClose":30.64,"prevWeekClose":3.645,"prevMonthClose":3.85,"prevQuarterClose":3.85,"fiveDayClose":3.645,"twentyDayClose":4.125,"sixtyDayClose":7.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02591","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775750400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-10-15","current":-3.838036,"percent":0.968531,"low":-137.156472,"twenty":-64.894515,"median":-40.291124,"eighty":-10.379801,"high":-4.018047,"avg":-40.249758,"sd":31.205124,"marketCap":1665106527},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327},{"date":"2026-02-13","current":-50.165477,"twenty":-79.691019,"median":-62.941647,"eighty":-57.039695,"marketCap":12608214032},{"date":"2026-02-20","current":-50.419859,"twenty":-79.623791,"median":-62.643943,"eighty":-56.891323,"marketCap":12653895967},{"date":"2026-02-27","current":-50.052949,"twenty":-79.470699,"median":-62.017016,"eighty":-56.651056,"marketCap":12699577902},{"date":"2026-03-06","current":-43.88908,"twenty":-79.397543,"median":-60.902753,"eighty":-56.29247,"marketCap":11045891858},{"date":"2026-03-13","current":-39.965904,"twenty":-79.214462,"median":-60.292057,"eighty":-54.71959,"marketCap":10104843999},{"date":"2026-03-20","current":-39.174717,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"marketCap":9867297938},{"date":"2026-03-27","current":-24.701097,"twenty":-78.775514,"median":-59.491697,"eighty":-50.290678,"marketCap":9547524394},{"date":"2026-04-02","current":-24.535908,"twenty":-78.383597,"median":-58.823921,"eighty":-50.052949,"marketCap":9529251620},{"date":"2026-04-10","current":-24.978414,"twenty":-78.348547,"median":-58.584467,"eighty":-49.631191,"marketCap":9775934068},{"date":"2026-04-17","current":-23.474521,"twenty":-78.227102,"median":-58.112982,"eighty":-48.421657,"marketCap":9191205301},{"date":"2026-04-24","current":-19.658213,"twenty":-78.155492,"median":-57.844151,"eighty":-44.116877,"marketCap":7697406030},{"date":"2026-04-30","current":-16.329046,"twenty":-77.825679,"median":-57.660489,"eighty":-41.074266,"marketCap":6395470886},{"date":"2026-05-08","current":-17.822364,"twenty":-77.322024,"median":-57.626503,"eighty":-40.478309,"marketCap":5778764764},{"date":"2026-05-15","current":-17.368107,"twenty":-77.157551,"median":-57.517602,"eighty":-40.012158,"marketCap":5646287153},{"date":"2026-05-22","current":-17.112125,"twenty":-76.782452,"median":-57.446424,"eighty":-25.37304,"marketCap":5550355090},{"date":"2026-05-29","current":-15.607197,"twenty":-76.252433,"median":-57.23775,"eighty":-24.916387,"marketCap":5079831160},{"date":"2026-06-05","current":-14.014909,"twenty":-75.020932,"median":-57.073515,"eighty":-24.414835,"marketCap":4568193490},{"date":"2026-06-12","current":-11.752443,"twenty":-74.621039,"median":-56.924891,"eighty":-23.900197,"marketCap":3828146144},{"date":"2026-06-18","current":-10.549084,"twenty":-74.404407,"median":-56.73827,"eighty":-23.474521,"marketCap":3444417891},{"date":"2026-06-26","current":-9.60263,"twenty":-74.160764,"median":-56.642046,"eighty":-20.865982,"marketCap":3120076153},{"date":"2026-07-03","current":-11.351574,"twenty":-74.088566,"median":-56.533624,"eighty":-19.581214,"marketCap":3691100339},{"date":"2026-07-10","current":-11.238926,"twenty":-74.037218,"median":-56.208644,"eighty":-19.055481,"marketCap":3649986598},{"date":"2026-07-17","current":-10.540302,"twenty":-73.42668,"median":-55.144116,"eighty":-17.753872,"marketCap":3435281504},{"date":"2026-07-24","current":-10.636027,"twenty":-71.947117,"median":-53.621015,"eighty":-17.028947,"marketCap":3467258858},{"date":"2026-07-31","current":-10.1543,"twenty":-71.465685,"median":-51.153424,"eighty":-16.590446,"marketCap":3316508473},{"date":"2026-08-07","current":-10.609247,"twenty":-70.999854,"median":-50.412223,"eighty":-15.817726,"marketCap":3471827052},{"date":"2026-08-14","current":-9.215586,"twenty":-70.625283,"median":-50.222782,"eighty":-14.020929,"marketCap":3019575896},{"date":"2026-08-21","current":-5.675745,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"marketCap":1863822943},{"date":"2026-08-28","current":-4.445704,"twenty":-68.330506,"median":-49.617462,"eighty":-11.852702,"marketCap":1733629429},{"date":"2026-09-04","current":-4.209722,"twenty":-67.634909,"median":-49.247121,"eighty":-11.642751,"marketCap":1642265559},{"date":"2026-09-11","current":-4.665967,"twenty":-67.023292,"median":-47.343126,"eighty":-11.381044,"marketCap":1822709202},{"date":"2026-09-18","current":-4.496374,"twenty":-66.568075,"median":-44.268741,"eighty":-11.284155,"marketCap":1758754493},{"date":"2026-09-25","current":-4.522512,"twenty":-66.254011,"median":-42.078385,"eighty":-11.102429,"marketCap":1765606783},{"date":"2026-10-02","current":-4.359948,"twenty":-65.694759,"median":-40.875046,"eighty":-10.830949,"marketCap":1703936171},{"date":"2026-10-09","current":-4.202749,"twenty":-65.009184,"median":-40.498003,"eighty":-10.543815,"marketCap":1644549656},{"date":"2026-10-15","current":-4.247779,"twenty":-64.894515,"median":-40.291124,"eighty":-10.379801,"marketCap":1665106527}],"updateTime":1792846193370},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2676502743","title":"銀諾醫藥-B(02591.HK)：金柏獲委任為公司副總裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2676502743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676502743?lang=zh_tw&edition=fundamental","pubTime":"2026-10-19 18:13","pubTimestamp":1792404787,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117130640","title":"銀諾醫藥-B（02591）任命金柏為副總裁 負責全球商業化佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=1117130640","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117130640?lang=zh_tw&edition=fundamental","pubTime":"2026-10-19 18:12","pubTimestamp":1792404744,"startTime":"0","endTime":"0","summary":"2026年10月19日，广州银诺医药集团股份有限公司发布自愿性公告称，董事会已委任金柏先生为公司副总裁，自2026年10月19日起生效，负责集团整体产品商业化及相关事务。银诺医药-B董事会表示，金柏先生在医药产品销售、商业化运营、团队建设及体系化管理方面的经验将有助于公司在全球范围内的商业化布局和发展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676350760","title":"銀諾醫藥-B：委任金柏為副總裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2676350760","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676350760?lang=zh_tw&edition=fundamental","pubTime":"2026-10-19 18:10","pubTimestamp":1792404600,"startTime":"0","endTime":"0","summary":"南财智讯10月19日电，银诺医药-B（02591.HK）发布自愿公告，金柏先生已获委任为公司副总裁，主要负责集团整体产品商业化及相关其他事务，自2026年10月19日起生效。金柏先生在医药产品销售及商业化管理领域拥有超过20年的经验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610193900006720.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610193900006720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179283181","title":"銀諾醫藥-B任命Jin Bai為副總裁 自2026年10月19日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1179283181","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179283181?lang=zh_tw&edition=fundamental","pubTime":"2026-10-19 18:08","pubTimestamp":1792404493,"startTime":"0","endTime":"0","summary":"银诺医药-B宣布，任命Jin Bai为副总裁，该任命自2026年10月19日起正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676501933","title":"年內股價暴跌88%後，銀諾醫藥再迎人事震盪：商業化「操盤手」徐文潔辭任","url":"https://stock-news.laohu8.com/highlight/detail?id=2676501933","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676501933?lang=zh_tw&edition=fundamental","pubTime":"2026-10-19 17:05","pubTimestamp":1792400745,"startTime":"0","endTime":"0","summary":"2022年4月，徐文洁加入银诺医药出任高级副总裁，同年11月获委任为董事，2024年10月调任执行董事，负责公司整体产品商业化及业务拓展。银诺医药在招股书中提到，徐文洁正在领导公司的依苏帕格鲁肽α的商业化工作。而截至2026年10月16日收盘，公司股价报3.65港元，总市值约16.65亿港元，年初至今跌幅约88%。银诺医药方面，在同日生效的另一项安排中，执行董事黄冰获委任为战略委员会委员，填补徐文洁留下的空缺。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1792400248879138100","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676954998","title":"銀諾醫藥商業化一號位徐文潔辭任，核心產品依蘇帕格魯肽α醫保落地正處爬坡期","url":"https://stock-news.laohu8.com/highlight/detail?id=2676954998","media":"红星资本局","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676954998?lang=zh_tw&edition=fundamental","pubTime":"2026-10-17 16:20","pubTimestamp":1792225234,"startTime":"0","endTime":"0","summary":"红星资本局10月17日消息，10月16日晚，港股创新药公司银诺医药（2591.HK）披露两项人事变动：徐文洁已辞任执行董事、董事会战略委员会委员及本公司副总裁，衡磊已辞任非执行董事，理由均是“投放更多时间处理其个人事务”；执行董事黄冰接替徐文洁进入战略委员会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610173899047089.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610173899047089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186057224","title":"銀諾醫藥-B宣佈兩名董事辭任並調整戰略委員會成員","url":"https://stock-news.laohu8.com/highlight/detail?id=1186057224","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186057224?lang=zh_tw&edition=fundamental","pubTime":"2026-10-16 21:00","pubTimestamp":1792155642,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司10月16日晚间公告称，公司董事会收到两名董事的辞任报告，并同步完成战略委员会成员调整。同日起，执行董事黄冰获委任为战略委员会委员。公告显示，截至公告日，公司董事会由三名执行董事WANG QINGHUA、姜帆及黄冰，两名非执行董事HO KYUNG SHIK，以及三名独立非执行董事陶武平、宋瑞霖、陈向荣组成。公司董事会对徐文洁和衡磊在任期间的贡献表示感谢，并欢迎黄冰履新。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675924625","title":"銀諾醫藥-B(02591.HK)：徐文潔辭任執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2675924625","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675924625?lang=zh_tw&edition=fundamental","pubTime":"2026-10-16 20:58","pubTimestamp":1792155498,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675156561","title":"銀諾醫藥－Ｂ(02591)股價上升5.075%，現價港幣$3.83","url":"https://stock-news.laohu8.com/highlight/detail?id=2675156561","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675156561?lang=zh_tw&edition=fundamental","pubTime":"2026-10-16 13:34","pubTimestamp":1792128840,"startTime":"0","endTime":"0","summary":"[上升股]银诺医药－Ｂ(02591) 股价在下午01:34比前收市价上升5.075%，现股价为港币$3.83。至目前为止，今日最高价为$3.83，而最低价为$3.645。总成交量为256.5万股，总成交金额为港币$963.202万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260929144021365_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260929144021365_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610162876/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2610162876/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181632949","title":"銀諾醫藥-B：9月股本保持穩定，未有新增發行或回購","url":"https://stock-news.laohu8.com/highlight/detail?id=1181632949","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181632949?lang=zh_tw&edition=fundamental","pubTime":"2026-10-05 16:37","pubTimestamp":1791189452,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司于2026年10月5日发布2026年9月证券变动月报表。报告期为2026年9月1日至9月30日。报告显示，截至2026年9月30日，银诺医药-B注册股本总数为人民币456,819,349元，维持不变。报告期内，上述股份数量均无增减变化。公司在本月并未发生任何新增发行、回购、注销或库藏股等变动。本次公告由公司联席公司秘书杨东妍签署。银诺医药-B重申将继续严格遵守香港联交所《上市规则》及相关法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105926314","title":"銀諾醫藥-B2026年中期營收7,821.80萬元 按年增長38.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105926314","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105926314?lang=zh_tw&edition=fundamental","pubTime":"2026-09-28 21:13","pubTimestamp":1790601202,"startTime":"0","endTime":"0","summary":"根据银诺医药-B披露的2026年中期报告，期内实现营收7,821.80万元，同比增长38.56%。报告期内，毛利率为72.50%，相较上年同期89.40%有所下降。从费用结构来看，研发投入为8,529.20万元，相比上年同期的9,908.20万元减少13.90%。销售及分销开支达到6,255.00万元，同比增加42.05%；行政开支为2,670.60万元，同比下降15.36%。经营活动所用现金流量净流出13,536.00万元，上年同期为8,685.20万元，经营性净现金流出同比增加约55.88%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"银诺医药-B2026年中期营收7,821.80万元 同比增长38.56%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2670832232","title":"銀諾醫藥－Ｂ(02591)股價下跌5.045%，現價港幣$3.67","url":"https://stock-news.laohu8.com/highlight/detail?id=2670832232","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670832232?lang=zh_tw&edition=fundamental","pubTime":"2026-09-28 11:43","pubTimestamp":1790566980,"startTime":"0","endTime":"0","summary":"[下跌股]银诺医药－Ｂ(02591) 股价在上午11:42比前收市价下跌5.045%，现股价为港币$3.67。至目前为止，今日最高价为$4.095，而最低价为$3.67。总成交量为635.24万股，总成交金额为港币$2.454千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609282110/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609282110/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666320","title":"黃冰增持銀諾醫藥-B(02591.HK)2400股 每股作價3.89港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666320","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666320?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:44","pubTimestamp":1789386264,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127325384","title":"銀諾醫藥-B：Cowin Capital Investment III Limited減持，好倉比例降至2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127325384","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127325384?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:23","pubTimestamp":1789118631,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment III Limited于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。Cowin Capital Investment III Limited此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196120627","title":"銀諾醫藥-B：Cowin China Growth Fund II, L.P.減持，好倉比例降至2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196120627","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196120627?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 17:12","pubTimestamp":1789117940,"startTime":"0","endTime":"0","summary":"Cowin China Growth Fund II, L.P.于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。Cowin China Growth Fund II, L.P.此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114700606","title":"銀諾醫藥-B：Cowin Capital Investment Limited減持，好倉比例由3.43%降至2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114700606","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114700606?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:46","pubTimestamp":1789033584,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment Limited于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。Cowin Capital Investment Limited此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168898987","title":"銀諾醫藥-B：Cowin Capital Investment II LTD減持，好倉比例降至2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168898987","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168898987?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:32","pubTimestamp":1789032777,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment II LTD于2026年9月10日以每股均价3.8185港元卖出银诺医药-B股份399.00万股，涉资约1523.58万港元。Cowin Capital Investment II LTD此次减持前持有银诺医药-B好仓1441.64万股，占比3.43%；减持后持股量为1042.64万股，好仓比例降至2.48%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115796288","title":"銀諾醫藥-B：黃荔減持，好倉比例降至4.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115796288","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115796288?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:22","pubTimestamp":1789032137,"startTime":"0","endTime":"0","summary":"黄荔于2026年9月10日以每股均价3.819港元卖出银诺医药-B（02591）股份519.00万股，涉资约1982.06万港元。黄荔此次减持前持有银诺医药-B好仓2479.11万股，占比5.9%；减持后持股量为1960.11万股，好仓比例降至4.66%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101858139","title":"銀諾醫藥-B：鄭偉鶴減持，好倉比例降至4.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101858139","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101858139?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:16","pubTimestamp":1789031770,"startTime":"0","endTime":"0","summary":"于2026年9月10日，郑伟鹤以每股均价3.819港元卖出银诺医药-B股份519.00万股，涉资约1982.06万港元。郑伟鹤此次减持前持有银诺医药-B好仓2479.11万股，占比5.9%；减持后持股量为1960.11万股，好仓比例降至4.66%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180452237","title":"銀諾醫藥-B：鄭偉鶴減持，好倉比例降至5.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180452237","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180452237?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 17:24","pubTimestamp":1788945849,"startTime":"0","endTime":"0","summary":"郑伟鹤于2026年9月8日以每股均价3.6115港元卖出银诺医药-B股份440.00万股，涉资约1589.06万港元。郑伟鹤此次减持前持有银诺医药-B好仓2919.11万股，占比6.95%；减持后持股量为2479.11万股，好仓比例降至5.9%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":123,"code":"91000000","status":"200"}]}}